(Q83054376)
Statements
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy (English)
Omar Serri
Ling Li
Marie-Claude Beauchamp
Fritz Maingrette
Geneviève Renier
scientific article published on 01 April 2006